BOTTOM LINE eps report was really bad even though insiders try really hard to sugar coat it.
When INSIDERS get back on track, only then is this a potential buy.
that for any reason REVERSE SPLIT. I do wish you the best of luck.
Yep you could write a book supporting a SHORT play here, but the REAL money here's already been made on the SHORT PLAY since mid 2's
Hell, even LYLE the board cheer leader here who continues to rate MNGA's stock a STRONG BUY, seems to have finally burned his cheer leading skirt lol.
at this company continues and imho, another insider PR spew won't find nearly as many FOOLS here to blindly chase the stock higher, for the benefit of insiders selling.
Anyone who has read postings here by us, told anyone who would listen, to join us in the mid 2's and short the hell out of this stock. Some of you did, but the majority of you failed to and now are major bag holders.
Fund raising here will likely come at the DILUTION of common share holders. Personally, I think the company should cut it's losses and file for bankruptcy.
PS. STRONG SHORT
I don't invest / trade stocks with reverse splits. The bulk of them end up in bankruptcy, wiping out common shareholders. CLSN has 2 reverse splits.
I've been working hard to find the next BIOTECH under $5.00 and believe "GERN" could get bought out.
If any of you have some small cap bio's you'd like to share, post them.
CAUTION....Don't become a bag holder here.
Yes you did. Nice call. Pretty much done trading here. Taking the wife out on our road bike to Lake Cushman in WA state.
Can't find any news wire on today's pop, but undervalued usually finds buyers and perhaps short squeeze as well. A close above $5.00 could set up next week for another pop, especially if there's a catalyst I'm not aware of yet. Many institutional investment entities won't buy stocks under $5.00 per share.
BUMMER I didn't get a chance to buy back some shares in the 3's lol
Once approved, it will be interesting to see the pricing of treatments, especially given the lower patient need. I was an early investor in the 7's on DNDN and sold all shares day of FDA approval. The drug was so expensive, the company went from upper 50's per share to ZERO. My only regret, I failed to short after dumping my long position.
Look at the patient need at NERV. It's huge and one to keep an eye on for buys of the stock if and when it comes back in and ahead of PHASE III results.
I tried to get you in EARLY, but guess you da penny stock dude.
Makes me think something big could be happening ahead of next Tuesday. Perfect time to release upside news if that's the plan. Great volume this early in the day as well.
Guess I won't be getting my 3's anytime soon lol.
If not a public company and assuming those running this for ever non profitable entitiy, pretty sure they would've jumped ship long ago.That said, pretty obvious most shareholders here already have.
Answer: Never because you can't even do basic elementary DD.
Blah blah blah......Yes I understand. All you "LONGS" made a killing as this stock tanked from $2.50 per share. In fact, all you longs here some how make money each time this stock tanks under a buck.
Funny how none of you EVER post real time trades, but yet here's another after the fact long claming how much MONEY he's made.
Maybe a good short here.